How do COPD patients respond to exacerbations?

<p>Abstract</p> <p>Background</p> <p>Although timely treatment of COPD exacerbations seems clinically important, nearly half of these exacerbations remain unreported and subsequently untreated. Recent studies have investigated incidence and impact of failure to seek med...

Full description

Bibliographic Details
Main Authors: Verheij Theo JM, de Weert-van Oene Gerdien H, Bourbeau Jean, Monninkhof Evelyn M, Schaap David, Trappenburg Jaap CA, Lammers Jan-Willem J, Schrijvers Augustinus JP
Format: Article
Language:English
Published: BMC 2011-08-01
Series:BMC Pulmonary Medicine
Online Access:http://www.biomedcentral.com/1471-2466/11/43
id doaj-8555e843ecde49e1aa2ef69ae7a3cdf2
record_format Article
spelling doaj-8555e843ecde49e1aa2ef69ae7a3cdf22020-11-24T21:32:26ZengBMCBMC Pulmonary Medicine1471-24662011-08-011114310.1186/1471-2466-11-43How do COPD patients respond to exacerbations?Verheij Theo JMde Weert-van Oene Gerdien HBourbeau JeanMonninkhof Evelyn MSchaap DavidTrappenburg Jaap CALammers Jan-Willem JSchrijvers Augustinus JP<p>Abstract</p> <p>Background</p> <p>Although timely treatment of COPD exacerbations seems clinically important, nearly half of these exacerbations remain unreported and subsequently untreated. Recent studies have investigated incidence and impact of failure to seek medical treatment during exacerbations. Yet, little is known about type and timing of other self-management actions in periods of symptom deterioration. The current prospective study aims at determining the relative incidence, timing and determinants of three types of patient responses.</p> <p>Methods</p> <p>In a multicentre observational study, 121 patients (age 67 ± 11 years, FEV<sub>1</sub>pred. 48 ± 19) were followed for 6 weeks by daily diary symptom recording. Three types of action were assessed daily: planning periods of rest, breathing techniques and/or sputum clearing (type-A), increased bronchodilator use (type-B) and contacting a healthcare provider (type-C).</p> <p>Results</p> <p>Type-A action was taken in 70.7%, type-B in 62.7% and type C in 17.3% of exacerbations (n = 75). Smokers were less likely to take type-A and B actions. Type-C actions were associated with more severe airflow limitation and increased number of hospital admissions in the last year.</p> <p>Conclusions</p> <p>Our study shows that most patients are willing to take timely self-management actions during exacerbations. Future research is needed to determine whether the low incidence of contacting a healthcare provider is due to a lack of self-management or healthcare accessibility.</p> http://www.biomedcentral.com/1471-2466/11/43
collection DOAJ
language English
format Article
sources DOAJ
author Verheij Theo JM
de Weert-van Oene Gerdien H
Bourbeau Jean
Monninkhof Evelyn M
Schaap David
Trappenburg Jaap CA
Lammers Jan-Willem J
Schrijvers Augustinus JP
spellingShingle Verheij Theo JM
de Weert-van Oene Gerdien H
Bourbeau Jean
Monninkhof Evelyn M
Schaap David
Trappenburg Jaap CA
Lammers Jan-Willem J
Schrijvers Augustinus JP
How do COPD patients respond to exacerbations?
BMC Pulmonary Medicine
author_facet Verheij Theo JM
de Weert-van Oene Gerdien H
Bourbeau Jean
Monninkhof Evelyn M
Schaap David
Trappenburg Jaap CA
Lammers Jan-Willem J
Schrijvers Augustinus JP
author_sort Verheij Theo JM
title How do COPD patients respond to exacerbations?
title_short How do COPD patients respond to exacerbations?
title_full How do COPD patients respond to exacerbations?
title_fullStr How do COPD patients respond to exacerbations?
title_full_unstemmed How do COPD patients respond to exacerbations?
title_sort how do copd patients respond to exacerbations?
publisher BMC
series BMC Pulmonary Medicine
issn 1471-2466
publishDate 2011-08-01
description <p>Abstract</p> <p>Background</p> <p>Although timely treatment of COPD exacerbations seems clinically important, nearly half of these exacerbations remain unreported and subsequently untreated. Recent studies have investigated incidence and impact of failure to seek medical treatment during exacerbations. Yet, little is known about type and timing of other self-management actions in periods of symptom deterioration. The current prospective study aims at determining the relative incidence, timing and determinants of three types of patient responses.</p> <p>Methods</p> <p>In a multicentre observational study, 121 patients (age 67 ± 11 years, FEV<sub>1</sub>pred. 48 ± 19) were followed for 6 weeks by daily diary symptom recording. Three types of action were assessed daily: planning periods of rest, breathing techniques and/or sputum clearing (type-A), increased bronchodilator use (type-B) and contacting a healthcare provider (type-C).</p> <p>Results</p> <p>Type-A action was taken in 70.7%, type-B in 62.7% and type C in 17.3% of exacerbations (n = 75). Smokers were less likely to take type-A and B actions. Type-C actions were associated with more severe airflow limitation and increased number of hospital admissions in the last year.</p> <p>Conclusions</p> <p>Our study shows that most patients are willing to take timely self-management actions during exacerbations. Future research is needed to determine whether the low incidence of contacting a healthcare provider is due to a lack of self-management or healthcare accessibility.</p>
url http://www.biomedcentral.com/1471-2466/11/43
work_keys_str_mv AT verheijtheojm howdocopdpatientsrespondtoexacerbations
AT deweertvanoenegerdienh howdocopdpatientsrespondtoexacerbations
AT bourbeaujean howdocopdpatientsrespondtoexacerbations
AT monninkhofevelynm howdocopdpatientsrespondtoexacerbations
AT schaapdavid howdocopdpatientsrespondtoexacerbations
AT trappenburgjaapca howdocopdpatientsrespondtoexacerbations
AT lammersjanwillemj howdocopdpatientsrespondtoexacerbations
AT schrijversaugustinusjp howdocopdpatientsrespondtoexacerbations
_version_ 1725957592035885056